10366-71-9Relevant articles and documents
COMPOUNDS FOR TREATING CERTAIN LEUKEMIAS
-
Paragraph 0541-0542, (2020/03/28)
Provided herein are compounds, preferably compounds inhibiting tyrosine kinase enzymatic activity of a protein selected from Abelson protein (ABL1), Abelson-related protein (ABL2), or a chimeric protein BCR-ABL1, compositions thereof, and methods of their
Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
-
, (2008/06/13)
The present invention relates to the field of prodrugs of chemotherapeutic agents and method of use thereof.
Diphosphonic acid compounds and use for calcium metabolism disorders
-
, (2008/06/13)
The present invention provides compounds of the formula: STR1 The present invention also provides processes for the preparation of these compounds and pharmaceutical compositions containing them useful in treatment and prophylaxis of disorders of calcium metabolism.